Omeicos

Developer of synthetic omega 3 analogues for treating cardiovascular diseases

placeBerlin, Berlin, Germany calendar_todayFounded 2013 groups15 employees language omeicos.com

Registered entities

Social engagement

Social engagement: 1.3K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

11 investors on record; lead investors include Vesalius Biocapital Partners, Kfw, SMS group, HTGF.

Investor typeCountShare
Venture capital655%
Other / undisclosed545%

Recent activity

22 Jan 2026
Event
Mitocon - Insieme per lo Studio e la Cura delle Malattie Mitocondriali ODV Mitochondrial Disease Conference
7 Jan 2026
Event
JPMWeek
28 Oct 2025
Event
BIO-Europe Partnering Conference
Coming soon